Search results
Order by most recent / most popular / relevance
Results: 1-10 of 114
Teva Canada Innovation v. Attorney General of Canada
- Borden Ladner Gervais LLP
- -
- Canada
- -
- May 8 2013
The Patented Medicine Prices Review Board (the PMPRB) ordered Teva to pay the Crown approximately $2.4 million for selling its product at an
Intellectual property weekly abstracts bulletin
- Borden Ladner Gervais LLP
- -
- Canada
- -
- April 1 2013
The Court granted a Prohibition Order to AstraZeneca, preventing Ranbaxy from entering the market with a generic version of ompeprazole until the
Patent refused listing on the Patent Register
- Borden Ladner Gervais LLP
- -
- Canada
- -
- April 30 2012
The Federal Court dismissed a judicial review of a decision of the Minister of Health refusing to list a patent on the Patent Register
Court refuses to reconsider or vary its decision relating to redetermination
- Borden Ladner Gervais LLP
- -
- Canada
- -
- December 7 2010
The Patented Medicines Prices Review Board (PMPRB) made a decision that Teva’s product COPAXONE had been sold at an excessive price
Court grants motion to reopen trial and admit new evidence
- Borden Ladner Gervais LLP
- -
- Canada
- -
- April 27 2011
The Federal Court granted leave to reopen the trial and admit new evidence in a matter under reserve, in which no reasons or judgement have issued
NOC proceeding dismissed on the basis of overbreadth and a lack of sound prediction
- Borden Ladner Gervais LLP
- -
- Canada
- -
- February 13 2013
In this case, one claim of a patent was at issue in the proceeding. The claim related to the use of pregabalin or its racemate to treat pain. The
Divisional patent application can be filed by applicant not named in original application
- Borden Ladner Gervais LLP
- -
- Canada
- -
- December 15 2010
This case is a judicial review of a decision of the Commissioner of Patents where recognition of a patent application as a divisional application was denied
Lilly v. Apotex
- Borden Ladner Gervais LLP
- -
- Canada
- -
- September 29 2010
Eli Lilly brought suit against Apotex alleging that it infringed eight (8) process patents
Appeal of decision denying interlocutory injunction dismissed
- Borden Ladner Gervais LLP
- -
- Canada
- -
- July 4 2011
This was an appeal of a decision of the Federal Court, refusing an interlocutory motion
Commissioner cannot undo acceptance of maintenance fees
- Borden Ladner Gervais LLP
- -
- Canada
- -
- April 18 2011
In this case, the Court made several findings of fact relating to the timing of events
Current Search
- Workarea - Patents
- Workarea - Healthcare
- Author - Beverley Moore